A University of Idaho lab received $1.3 million from the Department of Defense to study early detection methods for ...
A new study published last week suggests the psychedelic drug MDMA, also known as Ecstasy or Molly, can reduce symptoms of post-traumatic stress disorder, and some expect the treatment to be approved ...
The U.S. Department of Veterans Affairs advocates standard treatments for PTSD, including "exposure-based" treatments, which involve having sufferers repeatedly re-experience the traumatic event. The ...
A randomized controlled trial in 234 military personnel and veterans from four Texas locations found clinically significant reductions in PTSD symptoms in more than 60 percent of patients and ...
NEW YORK, Jan. 19, 2022 /PRNewswire/ -- Neurovation Labs, Inc., a biotech company targeting physical biomarkers of PTSD for comprehensive diagnosis and treatment, today announced that the U.S. Patent ...
NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Neurovation Labs, Inc., a biotechnology company targeting physiological biomarkers of Post-traumatic Stress Disorder (PTSD) for comprehensive diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results